Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

This study has been completed.
Seoul National University Hospital
Information provided by (Responsible Party):
Clinical Research Center for Solid Tumor, Korea Identifier:
First received: June 13, 2009
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)